DRUG
Bright Minds Biosciences Inc
NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY
$84.65
-7.38% today
Updated 2026-06-05
Market cap
$583.72M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.45
Dividend yield
—
52W range
$23 – $124
Volume
0.2M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
20.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$165.67
+95.71%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 20.63 — safe zone
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-9.50M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-14.96M | $-7.37M | $-2.80M | $-12.23M | $-10.63M |
| EPS | — | — | — | — | $-2.45 |
| Free cash flow | $-13.59M | $-7.02M | $-1.85M | $-8.69M | $-9.50M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Bright Minds Biosciences Inc trades at $84.65. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 20.63, it sits in the safe zone.
Frequently asked questions
What is Bright Minds Biosciences Inc's stock price?
Bright Minds Biosciences Inc (DRUG) trades at $84.65.
Is Bright Minds Biosciences Inc overvalued?
Bright Minds Biosciences Inc carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Bright Minds Biosciences Inc (DRUG)?
The 12-month analyst consensus target is $165.67, about 95.7% above the current $84.65. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Bright Minds Biosciences Inc's Altman Z-Score is 20.63, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-8.93%
Beta-0.11
50D MA$80.98
200D MA$72.71
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week+0.00%
1 month-17.37%
3 months-4.42%
YTD-11.58%
1 year—
3 years—
5 years—